Head to Head Contrast: Nexeon Medsystems (OTCMKTS:NXNN) versus Vivani Medical (NASDAQ:VANI)

Vivani Medical (NASDAQ:VANI) and Nexeon Medsystems (OTCMKTS:NXNN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings for Vivani Medical and Nexeon Medsystems, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	0	0	1	0	3.00
Nexeon Medsystems	0	0	0	0	0.00

Vivani Medical currently has a consensus target price of $4.00, suggesting a potential upside of 277.36%. Given Vivani Medical’s stronger consensus rating and higher possible upside, research analysts plainly believe Vivani Medical is more favorable than Nexeon Medsystems.

Profitability

This table compares Vivani Medical and Nexeon Medsystems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-102.42%	-49.21%
Nexeon Medsystems	N/A	N/A	N/A

Earnings and Valuation

This table compares Vivani Medical and Nexeon Medsystems”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$25.65 million	($0.44)	-2.41
Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A

Insider and Institutional Ownership

6.8% of Vivani Medical shares are owned by institutional investors. 44.3% of Vivani Medical shares are owned by company insiders. Comparatively, 61.2% of Nexeon Medsystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility and Risk

Vivani Medical has a beta of 2.76, meaning that its share price is 176% more volatile than the S&P 500. Comparatively, Nexeon Medsystems has a beta of 6.98, meaning that its share price is 598% more volatile than the S&P 500.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

About Nexeon Medsystems

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.